fingolimod hydrochloride has been researched along with ovalbumin in 15 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 19,565 | 63 | 5,664 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Forrest, MJ; Koprak, SL; Nomura, N; Quackenbush, EJ; Rosen, H; Xie, JH | 1 |
Albert, R; Brinkmann, V; Dubois, G; Edwards, M; Jarai, G; Newson, C; Nicholls, A; Sawicka, E; Thomas, M; Walker, C | 1 |
Fujita, T; Hirose, R; Kohno, T; Kurio, W; Kusumoto, H; Matsumoto, N; Shimizu, T; Uchida, S; Watabe, K; Yamaguchi, S; Yanada, K | 1 |
Gohda, M; Higuchi, M; Ishikawa, I; Kagiyama, Y; Kiyono, H; Kunisawa, J; Kurashima, Y; Miura, F; Ogahara, I | 1 |
Brewer, JM; Bundick, RV; Choo-Kang, BS; Garside, P; Gibson, VB; Hutchison, S; Leishman, AJ; McInnes, IB | 1 |
Berin, MC; Blázquez, AB; Bromberg, JS; Getachew, H; Knight, AK; Lira, SA; Mayer, L | 1 |
Hendriks, RW; Hoogsteden, HC; KleinJan, A; Lambrecht, BN; Leman, K; van Nimwegen, M; Willart, M | 1 |
Chiba, K; Maeda, Y; Sato, N; Seki, N; Sugahara, K | 1 |
Engelhard, VH; Enriquez, HL; Fu, YX; Thompson, ED | 1 |
Feng, XJ; Li, X; Lu, W; Luo, Y; Tang, W; Yang, XY; Zuo, JP | 1 |
Lei, T; Liu, G; Peng, J; Sun, C; Wang, R; Wu, T; Xu, K; Zhang, L; Zhao, Y | 1 |
Hoogsteden, HC; Kleinjan, A; Lambrecht, BN; Leman, K; van Nimwegen, M | 1 |
Ding, Z; Heyman, B; Xu, H; Zhang, L | 1 |
Gao, C; Li, JB; Li, JJ; Li, M; Zhang, L; Zhu, Q; Zhuang, X | 1 |
El-Sheakh, AR; Makled, MN | 1 |
15 other study(ies) available for fingolimod hydrochloride and ovalbumin
Article | Year |
---|---|
Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Topics: Animals; Antigens; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Epitopes, T-Lymphocyte; Fingolimod Hydrochloride; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Growth Inhibitors; Immunosuppressive Agents; Injections, Subcutaneous; Interphase; Lymph Nodes; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Ovalbumin; Propylene Glycols; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine; Succinimides; Th1 Cells | 2003 |
The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Topics: Animals; Cell Proliferation; Chemotaxis, Leukocyte; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation; Lymph Nodes; Lymphocyte Activation; Lymphocyte Count; Mice; Mice, Inbred C57BL; Organ Specificity; Ovalbumin; Propylene Glycols; Receptors, Interleukin-2; Receptors, Lysosphingolipid; Respiratory System; Sphingosine; T-Lymphocytes, Regulatory | 2005 |
Preparation of antibodies against a novel immunosuppressant, FTY720, and development of an enzyme immunoassay for FTY720.
Topics: Administration, Oral; Animals; Antibodies; Antigen-Antibody Reactions; Female; Fingolimod Hydrochloride; Haptens; Immunoenzyme Techniques; Molecular Structure; Ovalbumin; Propylene Glycols; Rabbits; Sphingosine; Stereoisomerism; Structure-Activity Relationship | 2006 |
Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses.
Topics: Animals; B-Lymphocytes; Female; Fingolimod Hydrochloride; Immunoglobulin A; Immunosuppressive Agents; Intestinal Mucosa; Intestines; Lysophospholipids; Mice; Mice, Inbred BALB C; Ovalbumin; Peyer's Patches; Plasma Cells; Propylene Glycols; Sphingosine | 2008 |
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation.
Topics: Adoptive Transfer; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Division; Cell Movement; Cytokines; Eosinophilia; Female; Fingolimod Hydrochloride; Flow Cytometry; Humans; Immunosuppressive Agents; Lung; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Transgenic; Microscopy, Confocal; Models, Animal; Ovalbumin; Propylene Glycols; Receptors, Antigen, T-Cell; Sphingosine; Th2 Cells; Time Factors | 2009 |
A functional role for CCR6 on proallergic T cells in the gastrointestinal tract.
Topics: Adoptive Transfer; Animals; Antibodies; CD3 Complex; Cells, Cultured; Chemokine CCL20; Cholera Toxin; Diarrhea; Female; Fingolimod Hydrochloride; Food Hypersensitivity; Immunoglobulin E; Immunosuppressive Agents; Jejunum; Lymph Nodes; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Ovalbumin; Propylene Glycols; Receptors, CCR6; Sphingosine; Th2 Cells | 2010 |
United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation.
Topics: Animals; Asthma; Disease Models, Animal; Female; Fingolimod Hydrochloride; Inflammation; Mice; Mice, Inbred BALB C; Ovalbumin; Propylene Glycols; Rhinitis, Allergic, Perennial; Sphingosine; Th2 Cells | 2010 |
Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Topics: Adoptive Transfer; Animals; Bone Marrow; Cell Count; Cell Movement; Fingolimod Hydrochloride; Hypersensitivity, Delayed; Immunization; Lymphoid Tissue; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Ovalbumin; Oxadiazoles; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; T-Lymphocytes; Thiophenes | 2010 |
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
Topics: Adoptive Transfer; Animals; Antigen Presentation; Antigen-Presenting Cells; beta 2-Microglobulin; Carcinoma, Lewis Lung; CD11a Antigen; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Fingolimod Hydrochloride; Granzymes; Hyaluronan Receptors; Immunosuppressive Agents; Integrin alpha4; Interferon-gamma; Lymph Nodes; Lymphocyte Activation; Lysosomal Membrane Proteins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monophenol Monooxygenase; Neoplasms; Ovalbumin; Peptide Fragments; Propylene Glycols; Receptors, Antigen, T-Cell; Sphingosine; T-Lymphocyte Subsets | 2010 |
Synthesis and immunomodulating activity of new analogues of fingolimod.
Topics: Animals; Female; Fingolimod Hydrochloride; Immunologic Factors; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Propylene Glycols; Sphingosine; Structure-Activity Relationship; T-Lymphocytes | 2012 |
Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; Cell Count; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immune Tolerance; Immunity; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Isoxazoles; Leflunomide; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Mycophenolic Acid; Ovalbumin; Propylene Glycols; Sirolimus; Sphingosine; Spleen; T-Lymphocytes, Regulatory | 2012 |
Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model.
Topics: Administration, Topical; Animals; Apoptosis; Disease Models, Animal; Drug Delivery Systems; Eosinophils; Fingolimod Hydrochloride; Immunosuppressive Agents; Lysophospholipids; Mast Cells; Mice; Mice, Inbred Strains; Ovalbumin; Propylene Glycols; Random Allocation; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Sensitivity and Specificity; Sphingosine; Th2 Cells | 2013 |
Marginal zone B cells transport IgG3-immune complexes to splenic follicles.
Topics: Animals; Antigen-Antibody Complex; Antigens; B-Lymphocytes; Dendritic Cells, Follicular; Female; Fingolimod Hydrochloride; Germinal Center; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Ovalbumin; Propylene Glycols; Receptors, Complement 3d; Sphingosine; Spleen; Trinitrobenzenes | 2014 |
Fingolimod can act as a facilitator to establish the primary T-cell response with reduced need of adjuvants.
Topics: Animals; Antibodies; Cytokines; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Immunologic Factors; Injections, Subcutaneous; Mice, Inbred C57BL; Ovalbumin; T-Lymphocytes; Vaccines, Subunit | 2018 |
Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK/ERK signaling in mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Inflammation; Interleukin-13; Lung; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Ovalbumin | 2023 |